Benitec Biopharma to Participate in Upcoming Conferences in January and February

Core Viewpoint - Benitec Biopharma Inc. is actively participating in several upcoming conferences to showcase its advancements in gene therapy and its proprietary "Silence and Replace" platform [1][2]. Group 1: Upcoming Conferences - Benitec will participate in the Muscular Dystrophy Association Gene Therapy Summit from January 28 to 30, 2025, in Tucson, AZ [2]. - The company will also attend the Guggenheim SMID Cap Biotech Conference on February 5, 2025, in New York, NY, which will include 1x1 meetings [2]. - Additionally, Benitec will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, at 2:00 PM EST, with a format that includes both a presentation and 1x1 meetings [2]. Group 2: Company Overview - Benitec Biopharma Inc. is a clinical-stage biotechnology company based in Hayward, California, focusing on novel genetic medicines [4]. - The company utilizes its proprietary "Silence and Replace" DNA-directed RNA interference platform, which combines RNA interference with gene therapy to target disease-causing genes while delivering wildtype replacement genes [4]. - Benitec is developing therapeutics based on this platform for chronic and life-threatening conditions, including Oculopharyngeal Muscular Dystrophy (OPMD) [4].